Search Results - "Sleight, J. A"

Refine Results
  1. 1

    Prolonged sedation due to accumulation of conjugated metabolites of midazolam by Bauer, T M, Ritz, R, Haberthür, C, Ha, H R, Hunkeler, W, Sleight, A J, Scollo-Lavizzari, G, Haefeli, W E

    Published in The Lancet (British edition) (15-07-1995)
    “…Midazolam is a short-acting benzodiazepine routinely used in intensive-care medicine. Conjugates of its main metabolite, alpha-hydroxymidazolam, have been…”
    Get more information
    Journal Article
  2. 2

    5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential by Martin, J R, Bös, M, Jenck, F, Moreau, J, Mutel, V, Sleight, A J, Wichmann, J, Andrews, J S, Berendsen, H H, Broekkamp, C L, Ruigt, G S, Köhler, C, Delft, A M

    “…In vitro, (S)-2-(chloro-5-fluoro-indol-1-yl)-1-methylethylamine 1:1 C4H4O4 and (S)-2-(4,4,7-trimethyl-1,4-dihydro-indeno[1, 2-b]pyrrol-1-yl)-1-methylethylamine…”
    Get more information
    Journal Article
  3. 3

    The movement history and fault rock evolution of a reactivated crustal-scale strike-slip fault; the Walls Boundary fault zone, Shetland by Watts, L. M, Holdsworth, R. E, Sleight, J. A, Strachan, R. A, Smith, S. A. F

    Published in Journal of the Geological Society (01-09-2007)
    “…The Walls Boundary Fault Zone is a crustal-scale strike-slip fault that cuts Precambrian-Caledonian basement terranes in Shetland and has been interpreted as…”
    Get full text
    Journal Article
  4. 4

    Characterization of Ro 04‐6790 and Ro 63‐0563: potent and selective antagonists at human and rat 5‐HT6 receptors by Sleight, Andrew J, Boess, Frank G, Bös, Michael, Levet‐Trafit, Bernard, Riemer, Claus, Bourson, Anne

    Published in British journal of pharmacology (01-06-1998)
    “…This study describes the in vitro characterization of two potent and selective 5‐HT6 receptor antagonists at the rat and human recombinant 5‐HT6 receptor. In…”
    Get full text
    Journal Article
  5. 5

    Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides by Bourson, A, Borroni, E, Austin, R H, Monsma, Jr, F J, Sleight, A J

    “…The purpose of the present study was to determine possible physiological functions of the 5-ht6 receptor using antisense oligonucleotides (AOs) in male rats…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Effects of the 5-HT1D receptor antagonist GR127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis by SKINGLE, M, SLEIGHT, A. J, FENIUK, W

    Published in Neuropharmacology (01-04-1995)
    “…The involvement of 5-HT1D receptors in the regulation of 5-HT release in the guinea-pig brain was examined using the novel 5-HT1D receptor blocking drug…”
    Get full text
    Journal Article
  8. 8

    Investigation of stretching behaviour induced by the selective 5‐HT6 receptor antagonist, Ro 04–6790, in rats by Bentley, Jane C, Bourson, Anne, Boess, Frank G, Fone, Kevin C F, Marsden, Charles A, Petit, Nadine, Sleight, Andrew J

    Published in British journal of pharmacology (01-04-1999)
    “…The present study examined the effects of the selective 5‐HT6 receptor antagonist 4‐amino‐N‐(2, 6 bis‐methylamino‐pyrimidin‐4‐yl)‐benzene sulphonamide (Ro…”
    Get full text
    Journal Article
  9. 9

    Involvement of 5‐HT6 receptors in nigro‐striatal function in rodents by Bourson, Anne, Boess, Frank G, Bös, Michael, Sleight, Andrew J

    Published in British journal of pharmacology (01-12-1998)
    “…4‐Amino‐N‐(2,4 bis‐methylamino‐pyrimidin‐4‐yl) benzene sulphonamide (Ro 04‐6790) is a potent, selective and competitive antagonist for the 5‐HT6 receptor which…”
    Get full text
    Journal Article
  10. 10

    Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells by Boess, F G, Monsma, Jr, F J, Carolo, C, Meyer, V, Rudler, A, Zwingelstein, C, Sleight, A J

    Published in Neuropharmacology (01-04-1997)
    “…We have stably expressed the rat 5-HT6 receptor in HEK293 cells at a density of > 2 pmol/mg protein, as determined in equilibrium binding studies with [3H]-LSD…”
    Get full text
    Journal Article
  11. 11

    Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task by King, M V, Spicer, C H, Sleight, A J, Marsden, C A, Fone, K C F

    Published in Psychopharmacology (Berlin, Germany) (01-01-2009)
    “…Selective 5-ht(6) receptor antagonists like Ro 04-6790 prolong memory in many rodent preclinical paradigms, possibly by blocking tonic 5-HT-evoked GABA release…”
    Get full text
    Journal Article
  12. 12

    Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht6 receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task by King, M. V., Spicer, C. H., Sleight, A. J., Marsden, C. A., Fone, K. C. F.

    Published in Psychopharmacology (2009)
    “…Rationale Selective 5-ht 6 receptor antagonists like Ro 04-6790 prolong memory in many rodent preclinical paradigms, possibly by blocking tonic 5-HT-evoked…”
    Get full text
    Journal Article
  13. 13

    Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2J mice by Bourson, A, Kapps, V, Zwingelstein, C, Rudler, A, Boess, F G, Sleight, A J

    “…Audiogenic seizures can be induced in DBA/2J mice following intense auditory stimulation. A number of neurotransmitters, including 5-hydroxytryptamine (5-HT),…”
    Get full text
    Journal Article
  14. 14

    Identification of Residues in Transmembrane Regions III and VI that Contribute to the Ligand Binding Site of the Serotonin 5‐HT6 Receptor by Boess, Frank G., Monsma, Frederick J., Sleight, Andrew J.

    Published in Journal of neurochemistry (01-11-1998)
    “…: We have examined the ligand binding site of the serotonin 5‐HT6 receptor using site‐directed mutagenesis. Replacing the highly conserved Asp106 in…”
    Get full text
    Journal Article
  15. 15

    Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist : effects of apparent agonist affinities by SLEIGHT, A. J, STAM, N. J, MUTEL, V, VANDERHEYDEN, P. M. L

    Published in Biochemical pharmacology (12-01-1996)
    “…Previous work has shown that 5-hydroxytryptamine (5-HT)2A receptors can be radiolabelled with various radioligands, including partial agonists, such as…”
    Get full text
    Journal Article
  16. 16

    In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism by Crespi, F, Garratt, J C, Sleight, A J, Marsden, C A

    Published in Neuroscience (1990)
    “…The relationship between 5-hydroxytryptamine release, metabolism and unit activity has been investigated in the anaesthetized rat. 5-Hydroxytryptamine release…”
    Get more information
    Journal Article
  17. 17

    In vivo effects of sumatriptan (GR 43175) on extracellular levels of 5-HT in the guinea pig by Sleight, A J, Cervenka, A, Peroutka, S J

    Published in Neuropharmacology (01-06-1990)
    “…The effect of sumatriptan, a selective 5-HT1D receptor agent, on extracellular levels of 5-HT in the frontal cortex of the guinea pig was measured by…”
    Get more information
    Journal Article
  18. 18

    Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment by Sleight, A J, Carolo, C, Petit, N, Zwingelstein, C, Bourson, A

    Published in Molecular pharmacology (01-01-1995)
    “…Due to the high level of expression of mRNA for the 5-hydroxytrytamine (5-ht7) receptor in the hypothalamus and the high affinity of 5-HT for this receptor,…”
    Get more information
    Journal Article
  19. 19

    Relationship between extracellular 5‐hydroxytryptamine and behaviour following monoamine oxidase inhibition and l‐tryptophan by Sleight, A.J., Marsden, C.A., Martin, K.F., Palfreyman, M.G.

    Published in British journal of pharmacology (01-02-1988)
    “…1 The present study investigates the effects of selective and a non‐selective monoamine oxidase (MAO) inhibitors combined with l‐tryptophan on MAO‐A and ‐B…”
    Get full text
    Journal Article
  20. 20